Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


European Commission launches consultation on nanotech safety

This article was originally published in RAJ Devices

Executive Summary

The European Commission’s Directorate General for Health is set to launch a public consultation on safety issues related to nanotechnology1. Results from the consultation will be used to help structure a one-day scientific hearing, set to take place on 10 September. The hearing will also focus, among other things, on the content of the recent opinion on the risk assessment of nanomaterials, published by the commission’s Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR)2,3.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts